Mapping genetic interactions in cancer: a road to rational combination therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mapping genetic interactions in cancer: a road to rational combination therapies ; volume:11 ; number:1 ; day:22 ; month:10 ; year:2019 ; pages:1-12 ; date:12.2019
Genome medicine ; 11, Heft 1 (22.10.2019), 1-12, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13073-019-0680-4
- URN
-
urn:nbn:de:101:1-2020021602483760956743
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tutuncuoglu, Beril
- Krogan, Nevan J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells